Clinical Trial Update: A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating peripheral blood–derived stem cell therapy for diabetic foot with critical limb ischemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot
• Leg Ulcers

Snippet

Sponsor: Beike Biotech India Pvt.ltd | Conditions: Diabetic Foot, Critical Limb Ischemia | Phase 1, Phase 2 | Status: UNKNOWN